Reduced mRNA and protein content of Rho guanine nucleotide exchange factor (RhoGEF) in Bartter's and Gitelman's syndromes: Relevance for the pathophysiology of hypertension

American Journal of Hypertension

Volumn 18, Issue 9, 2005, Pages 1200-1205

  Pagnin, Elisa ^a   Semplicini, Andrea ^a   Sartori, Michelangelo ^a   Pessina, Achille C ^a   Calò, Lorenzo A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Bartter's syndrome; Gitelman's syndrome; Hypertension; Rho kinase; RhoA; RhoGEF

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; MESSENGER RNA; PHOSPHOLIPASE C; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ADULT; ARTICLE; BARTTER SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ESSENTIAL HYPERTENSION; FEMALE; GENE EXPRESSION; GITELMAN SYNDROME; HUMAN; MALE; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; BARTTER SYNDROME; BLOTTING, WESTERN; FEMALE; GENE EXPRESSION; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; HYPERTENSION; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MUTATION; RECEPTORS, DRUG; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYMPORTERS; SYNDROME;

EID: 25144506965     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2005.03.747     Document Type: Article

References (28)

1. M.J. Berridge Inositol trisphosphate and calcium signalling Nature 361 1993 315 325
2. 2± sensitivity of smooth muscle and nonmuscle myosin II modulated by G-proteins, kinases, and myosin phosphatase Physiol Rev 83 2003 1325 1358
3. Y. Fukata, M. Amano, K. Kaibuki Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells TIPS 22 2001 32 39
4. K. Sward, M. Mita, D.P. Wilson, J.T. Deng, M. Susnjar, M.P. Walsh The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction Curr Hypertens Rep 5 2003 66 72
5. M. Uehata, T. Ishizaki, H. Satoh, T. Ono, T. Kawahara, T. Morishita, H. Tamakawa, K. Yamagami, J. Inui, M. Maekawa, S. Narumiya Calcium sensitization of smooth muscle mediated by a Kho-associated protein kinase in hypertension Nature 389 1997 990 994
6. A. Masumoto, Y. Hirooka, H. Shimokawa, K. Hironaga, S. Setoguchi, A. Takeshita Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans Hypertension 38 2001 1307 1310
7. K. Chitaley, D. Weber, R.C. Webb RhoA/Rho-kinase, vascular changes and hypertension Curr Hypertens Rep 3 2001 139 144
8. M. Higashi, H. Shimokawa, T. Hattori, J. Hiroki, Y. Mukai, K. Morikawa, T. Ichiki, S. Takahashi, A. Takeshita Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo. Effect on endothelial NAD(P)H oxidase system Circ Res 93 2003 767 775
9. T. Yamakawa, S. Tanaka, K. Numaguchi, Y. Yamakawa, E.D. Motley, S. Ichihara, T. Inagami Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells Hypertension 35 2000 313 318
10. C. Kataoka, K. Egashira, S. Inoue, M. Takemoto, W. Ni, M. Koyanagi, S. Kitamoto, M. Usui, K. Kaibuchi, H. Shimokawa, A. Takeshita Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats Hypertension 39 2002 245 250
11. K. Takeda, T. Ichiki, T. Tokunou, N. Iino, S. Fujii, A. Kitabatake, H. Shimokawa, A. Takeshita Critical role of Rho-kinase and MEK-ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression Arterioscler Thromb Vasc Biol 21 2001 868 873
12. Y. Eto, H. Shimokawa, J. Hiroki, K. Morishige, T. Kandabashi, Y. Matsumoto, M. Amano, M. Hoshijima, K. Kaibuchi, A. Takeshita Gene transfer of dominant negative Rho kinase suppresses neointimal formation after balloon injury in pigs Am J Physiol 278 2000 H1744 H1750
13. P.V. Sah, M.T. Seasholtz, A.S. Sagi, H.J. Brown The role of Rho in G protein-coupled receptor signal transduction Annu Rev Pharmacol Toxicol 40 2000 459 489
14. E.M. Ross, T.M. Wilkie GTPase-activating proteins for heterotrimeric G proteins regulators of G protein signaling (RGS) and RGS-like proteins Annu Rev Biochem 69 2000 795 827
15. Z. Ying, L. Jin, A.M. Dorrance, R.C. Webb Increased expression of mRNA for regulator of G protein signaling domain-containing Rho guanine nucleotide exchange factors in aorta from stroke-prone spontaneously hypertensive rats Am J Hypertens 17 2004 981 985
16. L. Calò, P.A. Davis, A. Semplicini Bartter's/Gitelman's syndrome a model for the relationships between hypertension, angiotensin II, oxidative stress and remodeling Clin Nephrol 59 2003 393 394
17. E. Pagnin, P.A. Davis, M. Sartori, A. Semplicini, A.C. Pessina, L.A. Calò Rho kinase and PAI-1 in Bartter's/Gitelman's syndromes relationship to angiotensin II signaling J Hypertens 22 2004 1963 1969
18. L. Calò, P.A. Davis, A. Semplicini Control of vascular tone in the syndromes of Bartter and Gitelman Crit Rev Clin Lab Sci 37 2000 503 522
19. L.A. Calò, E. Pagnin, P.A. Davis, M. Sartori, G. Ceolotto, A.C. Pessina, A. Semplicini Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension J Clin Endocrinol Metab 89 2004 4153 4157
20. L. Calò, G. Ceolotto, M. Milani, E. Pagnin, L.P. van den Heuvel, M. Sartori, P.A. Davis, R. Costa, A. Semplicini Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes Kidney Int 60 2001 882 889
21. L. Calò, P.A. Davis, A. Semplicini Reduced content of alpha subunit of Gq protein in monocytes of Bartter and Gitelman syndromes relationship with vascular hyporeactivity Kidney Int 61 2002 353 354
22. L. Calò, A. D'Angelo, S. Cantaro, M. Rizzolo, S. Favaro, A. Antonello, A. Borsatti Intracellular calcium signaling and vascular reactivity in Bartter's syndrome Nephron 72 1996 570 573
23. F. Di Virgilio, L. Calò, S. Cantaro, S. Favaro, A. Piccoli, A. Borsatti Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter's syndrome Clin Sci 72 1987 483 488
24. L.A. Calò, E. Pagnin, P.A. Davis, M. Sartori, A. Semplicini Oxidative stress-related factors in Bartter's and Gitelman's syndromes relevance for angiotensin II signalling Nephrol Dial Transplant 18 2003 1518 1525
25. L. Calò, G. Sartore, A. Bassi, C. Basso, S. Bertocco, R. Marin, S. Zambon, S. Cantaro, A. D'Angelo, P.A. Davis, E. Manzato, G. Crepaldi Reduced susceptibility of low density lipoprotein to oxidation in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome) J Hypertens 16 1998 1001 1008
26. L. Calò, P.A. Davis, M. Milani, S. Cantaro, A. Antonello, S. Favaro, A. D'Angelo Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome Relationship to vascular reactivity Clin Nephrol 51 1999 12 17
27. - and cyclic GMP levels in patients with Bartter's syndrome relationship to vascular reactivity Am J Kidney Dis 27 1996 874 879
28. S. Wolfrum, A. Dendorfer, Y. Rikitake, T.J. Stalker, Y. Gong, R. Scalia, P. Dominiak, P.K. Liao Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3 kinase/protein kinase Akt and cardiovascular protection Arterioscler Thromb Vasc Biol 24 2004 1842 1847